Bank of New York Mellon’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $81.7M | Sell |
808,034
-57,508
| -7% | -$5.96M | 0.01% | 768 |
|
|
2026
Q1 | $83.7M | Sell |
865,542
-20,789
| -2% | -$2.13M | 0.02% | 722 |
|
|
2025
Q4 | $94.1M | Sell |
886,331
-124,848
| -12% | -$14.5M | 0.02% | 678 |
|
|
2025
Q3 | $128M | Sell |
1,011,179
-27,560
| -3% | -$3.28M | 0.02% | 532 |
|
|
2025
Q2 | $127M | Sell |
1,038,739
-120,749
| -10% | -$13.8M | 0.02% | 521 |
|
|
2025
Q1 | $117M | Sell |
1,159,488
-155,832
| -12% | -$15.2M | 0.02% | 547 |
|
|
2024
Q4 | $121M | Sell |
1,315,320
-47,707
| -4% | -$4.68M | 0.02% | 559 |
|
|
2024
Q3 | $132M | Sell |
1,363,027
-150,482
| -10% | -$13.5M | 0.02% | 519 |
|
|
2024
Q2 | $130M | Sell |
1,513,509
-114,250
| -7% | -$9.59M | 0.02% | 522 |
|
|
2024
Q1 | $134M | Sell |
1,627,759
-139,093
| -8% | -$10.2M | 0.03% | 524 |
|
|
2023
Q4 | $118M | Sell |
1,766,852
-41,025
| -2% | -$2.66M | 0.02% | 577 |
|
|
2023
Q3 | $121M | Sell |
1,807,877
-40,735
| -2% | -$2.8M | 0.03% | 541 |
|
|
2023
Q2 | $125M | Sell |
1,848,612
-252,090
| -12% | -$15.8M | 0.03% | 542 |
|
|
2023
Q1 | $114M | Sell |
2,100,702
-4,965
| -0.2% | -$289K | 0.02% | 566 |
|
|
2022
Q4 | $126M | Sell |
2,105,667
-101,045
| -5% | -$5.5M | 0.03% | 517 |
|
|
2022
Q3 | $99.8M | Sell |
2,206,712
-378,981
| -15% | -$19M | 0.02% | 600 |
|
|
2022
Q2 | $115M | Sell |
2,585,693
-53,709
| -2% | -$2.76M | 0.03% | 557 |
|
|
2022
Q1 | $149M | Buy |
2,639,402
+659,631
| +33% | +$34.4M | 0.03% | 509 |
|
|
2021
Q4 | $103M | Buy |
1,979,771
+99,618
| +5% | +$5.14M | 0.02% | 688 |
|
|
2021
Q3 | $112M | Sell |
1,880,153
-6,432
| -0.3% | -$405K | 0.02% | 621 |
|
|
2021
Q2 | $117M | Buy |
1,886,585
+674
| +0% | +$44.9K | 0.02% | 629 |
|
|
2021
Q1 | $123M | Buy |
1,885,911
+54,822
| +3% | +$3.58M | 0.03% | 604 |
|
|
2020
Q4 | $120M | Sell |
1,831,089
-162,558
| -8% | -$9.56M | 0.03% | 576 |
|
|
2020
Q3 | $103M | Sell |
1,993,647
-327,896
| -14% | -$16.8M | 0.03% | 561 |
|
|
2020
Q2 | $114M | Buy |
2,321,543
+259,499
| +13% | +$14M | 0.03% | 491 |
|
|
2020
Q1 | $105M | Buy |
2,062,044
+435,383
| +27% | +$25.1M | 0.03% | 449 |
|
|
2019
Q4 | $89.6M | Buy |
1,626,661
+1,156
| +0.1% | +$62.7K | 0.02% | 650 |
|
|
2019
Q3 | $81.8M | Sell |
1,625,505
-55,950
| -3% | -$2.81M | 0.02% | 675 |
|
|
2019
Q2 | $84.8M | Sell |
1,681,455
-163,619
| -9% | -$7.94M | 0.02% | 671 |
|
|
2019
Q1 | $85.7M | Sell |
1,845,074
-28,945
| -2% | -$1.47M | 0.02% | 663 |
|
|
2018
Q4 | $92M | Buy |
1,874,019
+72,270
| +4% | +$4.11M | 0.03% | 563 |
|
|
2018
Q3 | $112M | Buy |
1,801,749
+27,360
| +2% | +$1.66M | 0.03% | 569 |
|
|
2018
Q2 | $95.6M | Sell |
1,774,389
-210,747
| -11% | -$10.5M | 0.03% | 611 |
|
|
2018
Q1 | $90.3M | Sell |
1,985,136
-12,285
| -0.6% | -$527K | 0.03% | 648 |
|
|
2017
Q4 | $78.5M | Sell |
1,997,421
-763
| -0% | -$29K | 0.02% | 750 |
|
|
2017
Q3 | $73.7M | Buy |
1,998,184
+164,679
| +9% | +$5.87M | 0.02% | 752 |
|
|
2017
Q2 | $70.6M | Buy |
1,833,505
+29,514
| +2% | +$1.08M | 0.02% | 762 |
|
|
2017
Q1 | $61.4M | Buy |
1,803,991
+182,569
| +11% | +$6M | 0.02% | 834 |
|
|
2016
Q4 | $53.2M | Buy |
1,621,422
+798,913
| +97% | +$25.9M | 0.02% | 907 |
|
|
2016
Q3 | $26.5M | Buy |
822,509
+4,205
| +0.5% | +$136K | 0.01% | 1277 |
|
|
2016
Q2 | $25.3M | Buy |
818,304
+1,231
| +0.2% | +$38.5K | 0.01% | 1255 |
|
|
2016
Q1 | $24.5M | Sell |
817,073
-186,065
| -19% | -$5.14M | 0.01% | 1284 |
|
|
2015
Q4 | $27.8M | Buy |
1,003,138
+52,478
| +6% | +$1.49M | 0.01% | 1183 |
|
|
2015
Q3 | $29M | Sell |
950,660
-99,028
| -9% | -$3.45M | 0.01% | 1172 |
|
|
2015
Q2 | $38.5M | Buy |
1,049,688
+23,664
| +2% | +$844K | 0.01% | 1052 |
|
|
2015
Q1 | $36.2M | Sell |
1,026,024
-738,269
| -42% | -$25.3M | 0.01% | 1087 |
|
|
2014
Q4 | $54M | Sell |
1,764,293
-793,242
| -31% | -$24.7M | 0.01% | 853 |
|
|
2014
Q3 | $75.1M | Sell |
2,557,535
-133,115
| -5% | -$4.06M | 0.02% | 679 |
|
|
2014
Q2 | $76.8M | Sell |
2,690,650
-198,845
| -7% | -$5.54M | 0.02% | 694 |
|
|
2014
Q1 | $82.6M | Buy |
2,889,495
+523,548
| +22% | +$13.6M | 0.02% | 649 |
|
|
2013
Q4 | $62.7M | Buy |
2,365,947
+31,635
| +1% | +$880K | 0.02% | 761 |
|
|
2013
Q3 | $64M | Sell |
2,334,312
-194,544
| -8% | -$4.99M | 0.02% | 734 |
|
|
2013
Q2 | $57.9M | Buy |
+2,528,856
| New | +$57.1M | 0.02% | 743 |
|
Other funds holding EHC
CCM
RP
CAM
TCM
Bank of New York Mellon's EHC Position: Q2 2026 in Review
Bank of New York Mellon reduced its Encompass Health (EHC) stake by 6.6% in Q2 2026, selling an estimated $5.96M and leaving 808,034 shares worth $81.7M. The position accounts for 0.01% of the portfolio, ranked #768.
Bank of New York Mellon first reported a position in EHC in Q2 2013 and has held it in 53 quarters since. The position peaked at $149M in Q1 2022. 341 funds tracked by Wall St. Rank hold EHC as of Q2 2026.
- Bank of New York Mellon held 808,034 shares of Encompass Health worth $81.7M as of Q2 2026.
- Bank of New York Mellon sold 57,508 Encompass Health shares in Q2 2026, an estimated $5.96M.
- Encompass Health made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #768 holding.
- Bank of New York Mellon first reported a position in Encompass Health in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Encompass Health position peaked at $149M in Q1 2022.
- 341 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.